Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guiyang Longtai Pharmaceutical is a Chinese pharmaceutical company based in Guiyang, Guizhou Province, specializing in the development and production of Traditional Chinese Medicine (TCM) and modern chemical drugs. Since its acquisition by Guizhou Yibai Pharmaceutical in 2014, the company has served as a significant manufacturing hub for the group's cardiovascular and respiratory product lines. Its portfolio features well-known products such as Xinnao Xin Capsules, which are utilized for treating cardiovascular and cerebrovascular conditions, and Compound Licorice Tablets for respiratory relief. The company operates advanced, GMP-certified facilities capable of producing various dosage forms, including capsules, tablets, and granules. Guiyang Longtai focuses primarily on the domestic Chinese market, leveraging regional herbal resources and modern pharmaceutical technology to provide therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guiyang Longtai Pharmaceutical.